Clinical Trial Update: Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for rituximab in treating moderate aplastic anemia, pure red cell aplasia, or Diamond-Blackfan anemia with completed status and results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Diamond-blackfan Anemia
• Pure Red Cell Aplasia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Anemia, Aplastic, Red-Cell Aplasia, Pure | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28